Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 3,236 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Major Depression
Interventions: Virtual reality; Behavioral
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 13 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington, Iowa

Conditions: Acne Vulgaris on the Face
Interventions: DispersinB Acne Cleanser; Device
Lead sponsor: Kane Biotech Inc; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Anterior Cruciate Ligament Reconstruction (ACLR)
Interventions: Bone-patellar Tendon-bone (BTB), Bone-patellar Tendon-bone (BTB) and Lateral Extra-Articular Tenodesis (LET); Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 16 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Oropharyngeal Squamous Cell Carcinoma (OPSCC), HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions: MRI; Diagnostic Test
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Personal Health Information, Incarcerated Individuals
Interventions: Personal Health Library (PerHL) + MyChart, Epic®MyChart; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hypovitaminosis D
Interventions: Vitamin D3, Calcium, and Vitamin C; Dietary Supplement
Lead sponsor: Atlantic Health System; Other
Eligibility: 6 Years to 21 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Mitral Regurgitation (MR)
Interventions: Capstan Compass Robotic System for Transcatheter Mitral Valve Replacement; Device
Lead sponsor: Capstan Medical; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 3
States / cities: San Francisco, California • Cincinnati, Ohio • Nashville, Tennessee

Conditions: Dementia
Interventions: Focused Ultrasound; Device
Lead sponsor: West Virginia University; Other
Eligibility: 45 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma
Interventions: [18F]-AraG radiotracer, Chemotherapy, Radiotherapy; Drug · Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT; Device
Lead sponsor: Morgan State University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Parkinson's Disease With Freezing of Gait
Interventions: CueStim; Device
Lead sponsor: Fortis Medical Devices Limited; Industry
Eligibility: 60 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 6
States / cities: Boca Raton, Florida • Daytona Beach, Florida • Atlanta, Georgia + 3 more

Conditions: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Interventions: Androgen Deprivation Therapy (ADT), Androgen Receptor Pathway Inhibitors (ARPIs); Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Myocardial Infarction (MI), Stroke
Interventions: Smartphone application Antshrike; Device
Lead sponsor: Stanford University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostate Cancer
Interventions: Pasritamig; Drug
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Autism Spectrum Disorder
Interventions: Opt-In Early Latinx intervention, Opt-In Early Rural Intervention; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Months and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Hartford, Connecticut • Portland, Oregon

Conditions: Pain, Postoperative
Interventions: AirSeal Insufflation system, DV5 Insufflation system; Device
Lead sponsor: SurgiQuest, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Myocarditis Acute
Interventions: Myocardial contrast echocardiography molecular imaging for inflammation; Diagnostic Test
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Depression - Major Depressive Disorder, Anxiety, PTSD - Post Traumatic Stress Disorder, Insomnia, Alcohol Use Disorder (AUD), Suicide Ideation
Interventions: Deaf CBT-TS; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Hypertension
Interventions: Telemedicine management of Hypertension, Usual Care; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Dementia
Interventions: I-HTC; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions: Survodutide, Placebo matching survodutide; Combination Product
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Peoria, Arizona • Los Angeles, California • Oxnard, California + 12 more

Conditions: Shoulder Pain, Shoulder Injuries
Interventions: CRISP: Criteria-Based Approach for the Rehabilitation for Non-Operative Shoulder Injuries, Standard of Care; Other
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Stroke, Dysarthria, Apraxia, Dysphagia, Hemiparesis After Stroke
Interventions: Boston Scientific Vercise Deep Brain Stimulation (DBS) System, Rehabilitation Training Protocol; Device · Other
Lead sponsor: Pirondini, Elvira, PhD; Other
Eligibility: 22 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8
Interventions: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Floxuridine, Intrahepatic Infusion Procedure, Leronlimab, Magnetic Resonance Imaging, Surgical Procedure, Systemic Therapy; Procedure · Drug · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 3
States / cities: Goodyear, Arizona • Duarte, California • Irvine, California

Search by objective public record fields.

Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)

Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris

The Effect of Lateral Extra-Articular Tenodesis on Lower-Extremity Lean Mass Recovery Following Anterior Cruciate Ligament Reconstruction

Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma

Personal Health Libraries for Formerly Incarcerated Individuals

The Effectiveness of a Weight-dependent Algorithm for Dosing Vitamin D.

Early Feasibility Study of the Capstan Medical TMVR System

Neuromodulation for Behavioral Changes in Neurological Disorders

[18F]-AraG PET Imaging in LA HNSCC

Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation

Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease

Testosterone-Informed De-Escalation in Metastatic Prostate Cancer (TIDE PC)

Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer

Opt-In Early Pilot Study

Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study

MCE Molecular Imaging for Myocarditis

Deaf CBT-TS to Reduce Suicide Risk

Tailoring TM-HTN Intervention for Black Patients

Inpatient Hospice Transitions Checklist

ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

Efficacy of a Criteria Based Clinical Pathway for Rehabilitation of Shoulder Injuries

Deep Brain Stimulation + Therapy for Stroke

CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial